Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott RealTime hepatitis C assays – implications for response-guided therapy in genotype 1 infections.

Veröffentlicht vonadmin

Taylor N, Haschke-Becher E, Greil R, Strasser M, Oberkofler H.

http://www.ncbi.nlm.nih.gov/pubmed/24430620